Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Extended antenatal antiretroviral use correlates with improved infant outcomes throughout the first year of life.

Marazzi MC, Liotta G, Nielsen-Saines K, Haswell J, Magid NA, Buonomo E, Scarcella P, Doro Altan AM, Mancinelli S, Palombi L.

AIDS. 2010 Nov 27;24(18):2819-26. doi: 10.1097/QAD.0b013e32833ff58c.

PMID:
20885282
2.

Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.

Marazzi MC, Palombi L, Nielsen-Saines K, Haswell J, Zimba I, Magid NA, Buonomo E, Scarcella P, Ceffa S, Paturzo G, Narciso P, Liotta G.

AIDS. 2011 Aug 24;25(13):1611-8. doi: 10.1097/QAD.0b013e3283493ed0.

PMID:
21673553
3.

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.

J Infect Dis. 2009 Nov 15;200(10):1490-7. doi: 10.1086/644598.

PMID:
19832114
4.

Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.

Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Mipando L, Nkanaunena K, Mebrahtu T, Bulterys M, Fowler MG, Taha TE.

N Engl J Med. 2008 Jul 10;359(2):119-29. doi: 10.1056/NEJMoa0801941. Epub 2008 Jun 4.

5.

Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women.

Marazzi MC, Germano P, Liotta G, Guidotti G, Loureiro S, da Cruz Gomes A, Valls Blazquez MC, Narciso P, Perno CF, Mancinelli S, Palombi L.

HIV Med. 2006 Jul;7(5):338-44.

6.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

7.

Response to antiretroviral therapy after a single, peripartum dose of nevirapine.

Lockman S, Shapiro RL, Smeaton LM, Wester C, Thior I, Stevens L, Chand F, Makhema J, Moffat C, Asmelash A, Ndase P, Arimi P, van Widenfelt E, Mazhani L, Novitsky V, Lagakos S, Essex M.

N Engl J Med. 2007 Jan 11;356(2):135-47.

8.

Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.

Onah HE, Ibeziako N, Nkwo PO, Obi SN, Nwankwo TO.

J Obstet Gynaecol. 2008 Apr;28(3):276-9. doi: 10.1080/01443610802042639.

PMID:
18569467
9.

Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.

Marazzi MC, Nielsen-Saines K, Buonomo E, Scarcella P, Germano P, Majid NA, Zimba I, Ceffa S, Palombi L.

Pediatr Infect Dis J. 2009 Jun;28(6):483-7. doi: 10.1097/INF.0b013e3181950c56.

PMID:
19483516
10.
11.

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.

PMID:
18753864
12.

Protecting the next generation--eliminating perinatal HIV-1 infection.

Mofenson LM.

N Engl J Med. 2010 Jun 17;362(24):2316-8. doi: 10.1056/NEJMe1004406. No abstract available.

13.

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

Tattevin P, Arvieux C, Courpotin C.

N Engl J Med. 2010 Nov 11;363(20):1968-9; author reply 1970. doi: 10.1056/NEJMc1009231#SA1. No abstract available.

PMID:
21067396
14.

International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.

Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N.

Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S42-55. Review.

PMID:
17825650
15.

Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.

Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, Harries AD, van Oosterhout JJ, Meguid T, Ben-Smith A, Zachariah R, Lynen L, Zolfo M, Van Damme W, Gilks CF, Atun R, Shawa M, Chimbwandira F.

Lancet. 2011 Jul 16;378(9787):282-4. doi: 10.1016/S0140-6736(10)62303-3. No abstract available.

PMID:
21763940
16.

Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.

TEmAA ANRS 12109 Study group, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouévi DK, Dabis F.

AIDS. 2009 Apr 27;23(7):825-33. doi: 10.1097/QAD.0b013e32832949d5.

PMID:
19307941
17.

Nevirapine and perinatal transmission.

[No authors listed]

AIDS Patient Care STDS. 2000 Apr;14(4):226. No abstract available.

PMID:
10806648
18.

HAART during pregnancy and during breastfeeding among HIV-infected women in the developing world: has the time come?

Bulterys M, Wilfert CM.

AIDS. 2009 Nov 27;23(18):2473-7. doi: 10.1097/QAD.0b013e328333866c. No abstract available.

PMID:
19838097
19.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
20.

Can a $4 drug stop vertical HIV transmission?

[No authors listed]

AIDS Alert. 1999 Nov;14(11):suppl 2-3.

PMID:
11366985

Supplemental Content

Support Center